Indirect immunofluorescence analyses of SMI treated or shRNA-PKM2 NSCLC cell lines revealed a significant decline in the extent of immuno-staining and the percentage of PKM2 positive cells compared to corresponding controls (S2 Table, P<0.0001). The gene discussed is PKM; the disease is non-small cell lung carcinoma.